A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Key facts

Sponsor

Target PharmaSolutions, Inc.

Enrollment

10000 enrolled

Eligibility

18 years · All sexes

Timeline

2016 – 2027

Study locations (30)

• Banner University Medical Center, Phoenix, Arizona, United States
• University of Arkansas, Little Rock, Arkansas, United States
• University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, United States
• Stanford University, Palo Alto, California, United States
• California Liver Research Institute, Pasadena, California, United States
• University of California-Davis, Sacramento, California, United States
• University of California, San Francisco, California, United States
• Georgetown University, Washington D.C., District of Columbia, United States
• Gastro Florida, Clearwater, Florida, United States
• University of Florida Hepatology Research at CTRB, Gainesville, Florida, United States
• University of Florida Health Gastroenterology, Jacksonville, Florida, United States
• Schiff Center for Liver Diseases/University of Miami, Miami, Florida, United States
• Tampa General Medical Group, Tampa, Florida, United States
• Piedmont Atlanta Hospital, Atlanta, Georgia, United States
• Piedmont Cancer Institute, Atlanta, Georgia, United States
• +15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Holt-Oram syndrome

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT03895645
  Connors Protocol for the Management and Use of Stored Human Specimens (Stored Human Specimens)
  National Institute of Allergy and Infectious Diseases (NIAID)
• RECRUITINGNANCT07352683
  Open TAP-block in Pediatric Abdominal Surgery
  Uppsala University
• RECRUITINGNANCT07301489
  Akershus Cardiac Examination (ACE) 5 Study
  University Hospital, Akershus
• RECRUITINGPHASE3NCT07000357
  A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
  AstraZeneca
• RECRUITINGPHASE1NCT06995729
  A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
  Pfizer
• RECRUITINGNCT06761105
  Using Anonymous Data From A Digital Tool for Medical History-Taking To Improve Healthcare Services
  University Hospital Goettingen
• ACTIVE NOT RECRUITINGNCT06735742
  A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer
  Pfizer
• ACTIVE NOT RECRUITINGPHASE2NCT06897748
  A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils
  AstraZeneca

See all trials for Holt-Oram syndrome →